Pacira BioSciences PCRX
NASDAQ PCRX
$36.33 -0.05 (-0.14%)
At close: Oct 21, 2026 · 4:00 PM EDT

Pacira BioSciences (PCRX) Acquisitions (2019 - 2026)

Updated

Pacira BioSciences' Acquisitions was $335,000 in Q1 2026, down 98.0% from $16.7 million a year earlier.

Analysis

Pacira BioSciences (PCRX) Acquisitions (2019 - 2026) Analysis & Trends

For FY2025, Acquisitions at Pacira BioSciences came in at $16.7 million.

  • Acquisitions shows a four-year compound annual growth rate of -55.3% (FY2021 to FY2025).
  • In earlier years, Acquisitions was $420.04 million in FY2021.
  • The Q1 2026 figure marks the lowest quarterly Acquisitions since Q4 2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 8.75 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn -17.24 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 23.00 Mn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 11.21 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Pacira BioSciences 1.43 Bn 495.69 Mn 148.24 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 335,000.00
Mar 31, 2025 16.70 Mn
Dec 31, 2019 -992,000.00
API Access

Pacira BioSciences Acquisitions API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=acquisitions&ticker=PCRX&period=max&api_key=YOUR_API_KEY